Short term follow-up of patients presenting with acute onset diabetes and diabetic ketoacidosis during an episode of COVID-19 (original) (raw)
Analysis of circulating tumour DNA to monitor disease burden following colorectal cancer surgery
F. Mortensen
Gut, 2015
View PDFchevron_right
The Level of Preoperative Plasma KRAS Mutations and CEA Predict Survival of Patients Undergoing Surgery for Colorectal Cancer Liver Metastases
Jindra Vrzalova Windrichova
Cancers
View PDFchevron_right
Significance of postoperative follow-up of patients with metastatic colorectal cancer using circulating tumor DNA
Kateřina Menclová
World Journal of Gastroenterology, 2019
View PDFchevron_right
Circulating tumor DNA dynamics and recurrence risk in patients undergoing curative intent resection of colorectal cancer liver metastases: A prospective cohort study
C. Underhill
PLOS Medicine, 2021
View PDFchevron_right
Minimal Residual Disease Detection using a Plasma-only Circulating Tumor DNA Assay in Patients with Colorectal Cancer
Jeffrey Clark
Clinical Cancer Research, 2021
View PDFchevron_right
Circulating Tumor DNA as a Biomarker for Monitoring Patients with Solid Cancers: Comparison with Standard Protein Biomarkers
Michael Duffy
Clinical Chemistry
View PDFchevron_right
Individualised multiplexed circulating tumour DNA assays for monitoring of tumour presence in patients after colorectal cancer surgery
Melissa Teo
Scientific reports, 2017
View PDFchevron_right
Clinical Applications of Minimal Residual Disease Assessments by Tumor-Informed and Tumor-Uninformed Circulating Tumor DNA in Colorectal Cancer
Yosef Nasseri
Cancers, 2021
View PDFchevron_right
Clinical implications of monitoring circulating tumor DNA in patients with colorectal cancer
Lone Vedel Schøler
Clinical cancer research : an official journal of the American Association for Cancer Research, 2017
View PDFchevron_right
Circulating tumour cells and cell-free DNA as a prognostic factor in metastatic colorectal cancer: the OMITERC prospective study
Pamela Pinzani
British Journal of Cancer, 2021
View PDFchevron_right
Plasma Circulating Tumor DNA in Pancreatic Cancer Patients Is a Prognostic Marker
Valerie Taly
Clinical Cancer Research, 2016
View PDFchevron_right
Circulating tumor cells (Ctc) and kras mutant circulating free Dna (cfdna) detection in peripheral blood as biomarkers in patients diagnosed with exocrine pancreatic cancer
Alfredo Carrato
BMC cancer, 2015
View PDFchevron_right
Utility of circulating tumor DNA for predicting prognosis in the management of resectable pancreatic cancer
Journal of Cancer Metastasis and Treatment, Akhil Chawla
Journal of Cancer Metastasis and Treatment, 2022
View PDFchevron_right
Free circulating DNA as a biomarker of colorectal cancer
alessandro marzorati
View PDFchevron_right
Circulating Tumor DNA in Precision Oncology and Its Applications in Colorectal Cancer
Sandra Fernandez
International Journal of Molecular Sciences
View PDFchevron_right
Early evaluation of circulating tumor DNA as marker of therapeutic efficacy in metastatic colorectal cancer patients (PLACOL study)
Valerie Taly
Clinical cancer research : an official journal of the American Association for Cancer Research, 2017
View PDFchevron_right
Circulating tumor DNA (ctDNA) as a pan-cancer screening test: is it finally on the horizon?
Michael Duffy
Clinical Chemistry and Laboratory Medicine (CCLM)
View PDFchevron_right
Circulating Tumor DNA as a Clinical Test in Resected Pancreatic Cancer
Stacy Mosier
Clinical Cancer Research, 2019
View PDFchevron_right
Cross-sectional analysis of circulating tumor DNA in primary colorectal cancer at surgery and during post-surgery follow-up by liquid biopsy
Giovanni Cigliana
Journal of Experimental & Clinical Cancer Research, 2020
View PDFchevron_right
Utility of cell-free tumour DNA for post-surgical follow-up of colorectal cancer patients
Petra Minarikova
PubMed, 2012
View PDFchevron_right
Preoperative detection of KRAS mutated circulating tumor DNA is an independent risk factor for recurrence in colorectal cancer
Yuji Kitahata
Scientific Reports
View PDFchevron_right
Circulating tumor DNA is a prognostic marker of tumor recurrence in stage II and III colorectal cancer: multicentric, prospective cohort study (ALGECOLS)
Valerie Taly
European Journal of Cancer, 2021
View PDFchevron_right
Frequent post-treatment monitoring of colorectal cancer using individualized ctDNA validated by multi-regional molecular profiling
Lance Liotta
2020
View PDFchevron_right
Ultrasensitive plasma ctDNA KRAS assay for detection, prognosis, and assessment of therapeutic response in patients with unresectable pancreatic ductal adenocarcinoma
hossein novin
Oncotarget, 2017
View PDFchevron_right
Circulating cell-free DNA in serum as a biomarker of colorectal cancer
Dalmo Almeida de Azevedo
Journal of Clinical Pathology, 2013
View PDFchevron_right
Circulating Cell Free DNA Integrity Index as a Biomarker for Response to Chemotherapy in Patients with Metastatic Colorectal Carcinoma
Doaa Mohamed
Asian Pacific Journal of Cancer Prevention, 2022
View PDFchevron_right
Use of Circulating Tumour DNA (ctDNA) for Measurement of Therapy Predictive Biomarkers in Patients with Cancer
Michael Duffy
Journal of Personalized Medicine, 2022
View PDFchevron_right
Methylated circulating tumor DNA as a biomarker for colorectal cancer diagnosis, prognosis, and prediction
Farah Nassar
Clinical Epigenetics
View PDFchevron_right
Circulating tumor DNA in cancer diagnosis, monitoring, and prognosis
Yusha Araf
2022
View PDFchevron_right
The Prognostic Value of Circulating Cell-Free DNA in Colorectal Cancer: A Meta-Analysis
shiva Basnet
Journal of Cancer, 2016
View PDFchevron_right
Circulating tumor cell-related transcripts in blood as prognostic biomarkers of early recurrence after liver resection for colorectal metastases
Agostino Maria De Rose
International Journal of Biological Markers, 2019
View PDFchevron_right
Circulating tumor DNA in blood: Future genomic biomarkers for cancer detection
Sobia Noreen
Experimental Hematology, 2018
View PDFchevron_right
Prognostic and predictive value of circulating tumor cell analysis in colorectal cancer patients
Ilja Kubisch
Journal of Translational Medicine, 2012
View PDFchevron_right